Cementless Total Knee Arthroplasty Market Trends

  • Report ID: 5395
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Cementless Total Knee Arthroplasty Market Trends

Growth Drivers

  • Aging Population and Increased Prevalence of Osteoarthritis: As people age, the risk of developing degenerative joint conditions like osteoarthritis increases significantly. Osteoarthritis is a leading cause of knee pain and disability. According to the World Health Organization (WHO), osteoarthritis affects more than 303 million people worldwide, making it a major contributor to the global burden of disease. As the population continues to age, the demand for knee replacement surgeries, including cementless TKA, is expected to grow.
  • Rising Research and Clinical Studies: Ongoing research and clinical studies are conducted to assess the long-term outcomes and benefits of cementless TKA. These studies provide valuable insights into the effectiveness and safety of cementless TKA implants. As more data becomes available, it informs clinical practice and helps in the development of improved implant designs. Surgeons and patients can make more informed decisions based on evidence from these studies.
  • Regulatory Environment and Quality Assurance: Regulatory bodies such as the Food and Drug Administration (FDA) in the United States and the CE Mark in Europe play a crucial role in ensuring the safety and efficacy of cementless TKA implants. Compliance with these regulations is vital for manufacturers. However, a well-established regulatory framework can also foster trust among surgeons and patients. The aging population, increasing prevalence of osteoarthritis, patient preferences, and advancements in technology all contribute to the growth of this market. Market competition and innovation play a pivotal role in pushing the boundaries of what is possible in cementless TKA. Cost considerations and the potential for long-term cost savings make cementless TKA an attractive option for both patients and healthcare providers. Regulatory oversight and ongoing research ensure quality and safety in the field.

Challenges

  • Reimbursement Issues: The cost of TKA procedures, including cementless TKA, can be significant. Insurance coverage and reimbursement policies can vary widely, and patients may face challenges in accessing the procedure due to cost constraints. Healthcare providers and patients often struggle with navigating complex reimbursement systems. Insurance coverage for cementless TKA can vary significantly based on the type of insurance plan, location, and individual policy terms. While some private health insurance plans may cover a substantial portion of the costs, others may provide limited coverage or require high deductibles and copayments. Additionally, patients with public insurance programs, such as Medicare and Medicaid, may experience differences in coverage depending on state regulations.
  • Lack of knowledge regarding the new technology of cementless total knee anthroplasty surgery
  • Increased cost of the recently developed features in the surgery

Cementless Total Knee Arthroplasty Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~8%

Base Year Market Size (2023)

~ USD 10 Billion

Forecast Year Market Size (2036)

~ USD 20 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5395
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing aging population is the major factor driving the market growth.

The market size of cementless total knee arthroplasty is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market Zimmer Biomet Holdings, Inc., Stryker Corporation, Johnson & Johnson (DePuy Synthes), Smith & Nephew plc, Medtronic plc (formerly known as Covidien), Conformis, Inc., and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying